Attenuation of extravasation of tissue plasminogen activator by the free radical scavenger, edaravone: Evaluation in a rat thromboembolic stroke model

Neurological Research

Volumn 27, Issue 5, 2005, Pages 499-502

  Kano, Tsuneo ^a   Harada, Tadashi ^a   Katayama, Yoichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Extravasation; Fibrinolysis; Free radical scavenger; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; NORPHENAZONE; SCAVENGER; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; DRUG EXTRAVASATION; FIBRINOLYSIS; MALE; NONHUMAN; PROTEIN DEGRADATION; RAT; RECANALIZATION; STROKE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPYRINE; BLOOD VESSELS; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FREE RADICAL SCAVENGERS; LASER-DOPPLER FLOWMETRY; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 22844448204     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X17387     Document Type: Article

References (13)

1. NINDS rt-PA Stroke Study Croup. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587
2. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SC, Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nature Med 1998; 4: 228-231
3. Chen Z-L, Stickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997; 91: 917-925
4. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997; 17: 543-552
5. Kano T, Katayama Y, Tejima E, Eng HL. Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke. Brain Res 2000; 854: 245-248
6. Korninger C, Collen D. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemostas 1981; 46: 561-565
7. Ranby M, Nguyen C, Scarabin PY, Samama M. Immunoreactivity of tissue plasminogen activator and its inhibitor complexes. Thromb Haemostas 1989; 61: 409-414
8. Watanabe T, Yu ki S, Egawa M, Nishi H. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 1994; 268: 1597-1604
9. Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988; 19: 480-485
10. Yamamoto T, Yuki S, Watanabe T, Mitsuka M, Saito K, Kogure K. Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia. Brain Res 1997; 762: 240-242
11. Watanabe T, Morita I, Nishi H, Murota S. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostagland Leuk Essent Fatty Acids 1988; 33: 81-87
12. Flavin MP, Zhao G, Ho LT. Microglial tissue plasminogen activator (tPA) triggers neuronal apoptosis in vitro. Glia 2000; 29: 347-354
13. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003; 15: 222-229